← 產業報告目錄

Healthcare Quality Management (QMS) Market by Offering [Software (Integrated), Service], Function (Compliance, Risk, Audit, CAPA, Change), Use Case (Quality, Analytics, Performance, Regulatory), End User (Hospital, ASC, Payer) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-10-21頁數 355報告編號 HIT5473

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global healthcare quality management (QMS) market is projected to reach USD 2.51 billion by 2030 from USD 1.42 billion in 2025, at a high CAGR of 12.1% during the forecast period. The healthcare quality management (QMS) market is progressing steadily, driven by the growing emphasis on patient safety, clinical quality, and outcome transparency. Rising regulatory requirements and government initiatives aimed at improving care standards are pushing providers to adopt structured quality management solutions. These systems enable hospitals and healthcare organizations to track performance metrics, manage risks, ensure compliance, and streamline reporting processes. However, despite strong adoption drivers, the sector faces persistent challenges. Chief among them are data quality and fragmentation across diverse healthcare IT systems, which hinder seamless integration and insights generation, along with the high implementation and maintenance costs of quality management platforms. Addressing these barriers will be crucial for the market to deliver on its promise of safer, more efficient, and accountable healthcare delivery. “By use case, the business intelligence & analytics segment is the largest segment during the forecast period.” The business intelligence (BI) & analytics segment accounts for the largest share of the healthcare quality management (QMS) market and is projected to maintain its lead in the coming years. This dominance is driven by the increasing need for data-driven decision-making, predictive insights, and performance optimization in healthcare organizations. BI and analytics solutions enable providers, payers, and administrators to analyze clinical, financial, and operational data in real time, supporting proactive quality improvement and regulatory compliance. By leveraging advanced analytics, healthcare institutions can identify care gaps, monitor patient outcomes, and streamline resource allocation, ultimately improving both efficiency and patient safety. The growing adoption of value-based care models and the shift toward personalized medicine further strengthen demand for BI-driven insights. Moreover, integration with cloud platforms and interoperability across diverse health IT systems enhances scalability and collaboration. As healthcare stakeholders continue to prioritize measurable quality outcomes and cost optimization, BI & analytics will remain the cornerstone use case, reinforcing its market leadership. “By offering, the software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period.” The software segment is expected to register the fastest growth in the healthcare quality management (QMS) market during the forecast period. This growth is driven by the rising demand for scalable, specialized, and flexible solutions that streamline quality management functions such as compliance reporting, risk assessment, incident tracking, performance monitoring, and patient safety management. Software solutions help healthcare organizations automate workflows, reduce administrative burden, and provide real-time visibility into quality metrics, enabling data-driven decision-making across departments. By centralizing and standardizing processes, these solutions minimize errors and ensure alignment with evolving regulatory requirements. The increasing adoption of cloud-based platforms, integration with EHRs, and advanced analytics capabilities are further accelerating software deployment. As healthcare providers focus on improving care quality, operational efficiency, and regulatory compliance, software offerings are poised to drive significant growth in the market over the forecast period. “The Asia Pacific is expected to witness the highest growth rate during the forecast period.” The Asia Pacific region is expected to register the fastest growth in the healthcare quality management (QMS) market over the forecast period. This growth is supported by rising government initiatives to strengthen healthcare systems, increasing investments in digital health technologies, and greater regulatory focus on patient safety and clinical quality. Rapid expansion of healthcare infrastructure, particularly in emerging economies such as India and China, is driving demand for advanced quality management solutions. The region’s growing chronic disease burden and aging population are further accelerating the need for robust platforms to track outcomes, reduce medical errors, and enhance efficiency in care delivery. Additionally, the increasing adoption of cloud-based healthcare IT solutions and growing collaborations between local providers and global technology vendors are enabling faster deployment of integrated quality management systems. Together, these factors position the Asia Pacific as the fastest-growing regional market, playing a pivotal role in shaping the future of healthcare quality management (QMS) worldwide. In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below: • By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%) • By Designation: Directors (15%), Managers (10%), and Others (75%) • By Region: North America (39%), Europe (31%), Asia Pacific (21%), Latin America (6%), and the Middle East & Africa (3%) Key Players in the Healthcare Quality Management (QMS) Market The key players operating in the healthcare quality management (QMS) market include Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), Intelex Technologies (Canada), DNV (Norway), RLDatix (US), Riskonnect, Inc. (US), HCI (Ireland), Ideagen (UK), Medisolv, Inc. (US), Vālenz Health (US), OdiTek Solutions (India), The Patient Safety Company (TPSC) (Netherlands), MorCare (Harris Health) (US), YouComply, Ltd. (ViClarity) (UK), SimplerQMS (US), NAVEX Global, Inc. (US), ProviderTrust (US), MedTrainer (US), OKKALA SOLUTIONS PRIVATE LIMITED (India), SafeQual (US), Effivity Technologies, Inc. (US), Title21 Health Solutions (US), Medblaze (INFINI) (India), eTaskPro (UAE), Qualityze (US), Karminn Consultancy Network (India), and MEG (Ireland). Research Coverage: The report analyzes the healthcare quality management (QMS) market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, use case, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market. This report provides insights into:  Analysis of key drivers (rising adoption of AI, ML, and predictive analytics in healthcare; increasing focus on patient safety and clinical quality; interoperability of health data & health information exchange; and growing regulatory requirements and government initiatives), restraints (data quality and fragmentation challenges across healthcare IT systems and high implementation and maintenance costs of quality management systems), opportunities (integration with patient-generated health data (PGHD) and voice and NLP for quality documentation), and challenges (data privacy and security concerns, standardization of quality measures & data models, and limited skilled workforce & training gaps) influencing the growth of the healthcare quality management (QMS) market.  Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare quality management (QMS) market.  Market Development: Comprehensive information on the lucrative emerging markets, offering, function, use case, end user, and region.  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare quality management (QMS) market  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare quality management (QMS) market, like Nuance Communications, Inc. (US), Premier Inc. (US), Optum, Inc. (US), RLDatix (US), and Intelex Technologies (Canada).
目錄 Table of Contents
1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.3 STUDY SCOPE 35 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35 1.3.2 INCLUSIONS & EXCLUSIONS 36 1.3.3 YEARS CONSIDERED 37 1.4 CURRENCY CONSIDERED 37 1.5 LIMITATIONS 38 1.5.1 METHODOLOGY-RELATED LIMITATIONS 38 1.5.2 SCOPE-RELATED LIMITATIONS 38 1.6 MARKET STAKEHOLDERS 38 1.7 SUMMARY OF CHANGES 39 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH APPROACH 40 2.1.1 SECONDARY RESEARCH 40 2.1.1.1 Key data from secondary sources 41 2.1.2 PRIMARY RESEARCH 42 2.1.2.1 Primary sources 42 2.1.2.2 Key data from primary sources 43 2.1.2.3 Breakdown of primaries 43 2.1.2.4 Insights from primary experts 44 2.2 RESEARCH METHODOLOGY DESIGN 44 2.3 MARKET SIZE ESTIMATION 45 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 49 2.5 MARKET SHARE ESTIMATION 49 2.6 STUDY ASSUMPTIONS 50 2.7 RESEARCH LIMITATIONS 50 2.7.1 METHODOLOGY-RELATED LIMITATIONS 50 2.8 RISK ASSESSMENT 50 3 EXECUTIVE SUMMARY 51   4 PREMIUM INSIGHTS 56 4.1 OPPORTUNITIES FOR PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 56 4.2 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING & COUNTRY 57 4.3 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57 4.4 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGIONAL MIX (2023–2030) 58 4.5 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2025 VS. 2030 (USD MILLION) 58 5 MARKET OVERVIEW 59 5.1 INTRODUCTION 59 5.2 MARKET DYNAMICS 59 5.2.1 DRIVERS 60 5.2.1.1 Rising adoption of AI, ML, and predictive analytics in healthcare 60 5.2.1.2 Increasing focus on patient safety and clinical quality 62 5.2.1.3 Interoperability of health data & health information exchange 62 5.2.1.4 Growing regulatory requirements and government initiatives 64 5.2.2 RESTRAINTS 65 5.2.2.1 Data quality and fragmentation challenges across healthcare IT systems 65 5.2.2.2 High implementation and maintenance costs of quality management systems 65 5.2.3 OPPORTUNITIES 66 5.2.3.1 Integration with patient-generated health data (PGHD) 66 5.2.3.2 Voice and NLP for quality documentation 66 5.2.4 CHALLENGES 67 5.2.4.1 Data privacy and security concerns 67 5.2.4.2 Standardization of quality measures & data models 69 5.2.4.3 Limited skilled workforce & training gaps 69 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70 5.4 INDUSTRY TRENDS 71 5.4.1 AI-DRIVEN PREDICTIVE ANALYTICS 71 5.4.2 INTEGRATION OF CLOUD-BASED QUALITY MANAGEMENT SOLUTIONS 72 5.4.3 EMPHASIS ON PATIENT-CENTERED CARE 72 5.4.4 REGULATORY COMPLIANCE AND RISK MANAGEMENT 72 5.4.5 CROSS-INDUSTRY COLLABORATION FOR INNOVATION 72 5.5 PRICING ANALYSIS 72 5.5.1 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024) 73 5.5.2 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024) 74 5.5.3 PRICING MODELS (QUALITATIVE) 75   5.6 VALUE CHAIN ANALYSIS 76 5.6.1 PRODUCT DESIGN & DEVELOPMENT 77 5.6.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION 77 5.6.3 IMPLEMENTATION 78 5.6.4 QUALITY ANALYTICS & REPORTING INSIGHTS 78 5.6.5 POST-SALES SERVICES 78 5.7 ECOSYSTEM ANALYSIS 78 5.8 INVESTMENT & FUNDING SCENARIO 81 5.9 TECHNOLOGY ANALYSIS 81 5.9.1 KEY TECHNOLOGIES 81 5.9.1.1 Quality measurement & reporting platforms 81 5.9.1.2 Performance & benchmarking analytics tools 82 5.9.1.3 Business intelligence (BI) & advanced analytics 82 5.9.2 COMPLEMENTARY TECHNOLOGIES 82 5.9.2.1 Interoperability/Health information exchange (HIE)/FHIR APIs 82 5.9.2.2 Telehealth & remote patient monitoring (RPM) 82 5.9.2.3 Data integration/Enterprise data warehouses & master data management 83 5.9.3 ADJACENT TECHNOLOGIES 83 5.9.3.1 Patient engagement platforms & portals (PROs) 83 5.9.3.2 Clinical documentation improvement (CDI) & coding/RCM systems 83 5.9.3.3 Automation & ambient clinician support (RPA, Voice/AI Scribing) 83 5.10 PATENT ANALYSIS 84 5.11 KEY CONFERENCES & EVENTS, 2025–2026 86 5.12 CASE STUDY ANALYSIS 87 5.12.1 CASE STUDY 1: DRIVING COST SAVINGS AND CARE QUALITY THROUGH UNIFIED DATA AND ANALYTICS 87 5.12.2 CASE STUDY 2: BOOSTING ACCURACY AND COMPLIANCE WITH AUTOMATED QUALITY REPORTING 87 5.12.3 CASE STUDY 3: IMPROVING CARE HOME COMPLIANCE AND OPERATIONAL EFFICIENCY THROUGH AUTOMATED QUALITY MANAGEMENT 88 5.13 REGULATORY ANALYSIS 88 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 5.13.2 REGULATORY LANDSCAPE 91 5.13.2.1 North America 91 5.13.2.2 Europe 92 5.13.2.3 Asia Pacific 92 5.13.2.4 Middle East & Africa 93 5.13.2.5 Latin America 93   5.14 PORTER’S FIVE FORCES ANALYSIS 94 5.14.1 BARGAINING POWER OF SUPPLIERS 95 5.14.2 BARGAINING POWER OF BUYERS 95 5.14.3 THREAT OF NEW ENTRANTS 96 5.14.4 THREAT OF SUBSTITUTES 96 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 96 5.15 KEY STAKEHOLDERS & BUYING CRITERIA 96 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 97 5.15.2 BUYING CRITERIA 98 5.16 UNMET NEEDS ANALYSIS 98 5.16.1 CURRENT UNMET NEEDS 98 5.16.2 END-USER EXPECTATIONS 100 5.17 BUSINESS MODEL ANALYSIS 101 5.17.1 SUBSCRIPTION-BASED (SAAS) MODEL 101 5.17.2 LICENSING & PERPETUAL SOFTWARE MODEL 101 5.17.3 PAY-PER-USE/TRANSACTION-BASED MODEL 101 5.17.4 ANALYTICS & BENCHMARKING SERVICES MODEL 101 5.17.5 QUALITY TRANSFORMATION & CONSULTING MODEL 101 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 102 5.18.1 INTRODUCTION 102 5.18.2 MARKET POTENTIAL OF AI/GEN AI IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 103 5.18.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 104 5.18.3.1 Transforming healthcare quality management (QMS) with AI-powered virtual care platforms 104 5.18.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105 5.18.4.1 Patient engagement solutions 105 5.18.4.2 Population health management 105 5.18.4.3 Patient safety software 106 5.18.5 USER READINESS AND IMPACT ASSESSMENT 106 5.18.5.1 User readiness 106 5.18.5.1.1 User A: Hospitals 106 5.18.5.1.2 User B: Outpatient & ambulatory care centers 106 5.18.5.2 Impact assessment 107 5.18.5.2.1 User A: Hospitals 107 5.18.5.2.2 User B: Outpatient & ambulatory care centers 107 5.19 IMPACT OF 2025 US TARIFFS ON HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 108 5.19.1 INTRODUCTION 108 5.19.2 KEY TARIFF RATES 108 5.19.3 PRICE IMPACT ANALYSIS 109 5.19.4 IMPACT ON COUNTRY/REGION 109 5.19.4.1 US 109 5.19.4.2 Europe 110 5.19.4.3 Asia Pacific 110 5.19.5 IMPACT ON END-USE INDUSTRIES 110 5.19.5.1 Healthcare providers 110 5.19.5.2 Healthcare payers 111 6 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING 112 6.1 INTRODUCTION 113 6.2 SOFTWARE 113 6.2.1 INTEGRATED SUITES 114 6.2.1.1 Increasing need for platforms to manage quality across entire care continuum to drive demand for integrated suites 114 6.2.2 POINT SOLUTIONS 115 6.2.2.1 Growing need for targeted tools that address specific challenges without need for enterprise-wide deployment to drive market 115 6.3 SERVICES 116 6.3.1 IMPLEMENTATION & TRAINING 118 6.3.1.1 Structured deployment and workforce training associated with implementation & training services to boost market 118 6.3.2 SUPPORT SERVICES 118 6.3.2.1 Ongoing technical assistance ensuring reliable performance of healthcare quality management (QMS) systems to support growth 118 6.3.3 CONSULTING SERVICES 119 6.3.3.1 Benefits such as strategic advisory and process optimization to drive demand for consulting services 119 6.3.4 OTHER SERVICES 120 7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION 121 7.1 INTRODUCTION 122 7.2 DOCUMENT MANAGEMENT 122 7.2.1 ADVANTAGES SUCH AS STANDARDIZED CLINICAL AND OPERATIONAL WORKFLOWS AND RELIABLE AUDIT TRAILS TO DRIVE DEMAND 122 7.3 RISK MANAGEMENT 123 7.3.1 RISING ADOPTION OF RISK MANAGEMENT SOLUTIONS FOR IMPROVING PATIENT SAFETY AND COMPLIANCE TO DRIVE GROWTH 123 7.4 AUDIT MANAGEMENT 124 7.4.1 GROWING ADOPTION OF AUDIT MANAGEMENT SYSTEMS TO ENHANCE OPERATIONAL EFFICIENCY TO SUPPORT MARKET 124 7.5 CAPA & NONCONFORMANCE MANAGEMENT 125 7.5.1 GROWING NEED FOR CAPA & NONCONFORMANCE MANAGEMENT TO ENHANCE HEALTHCARE QUALITY AND COMPLIANCE TO FUEL GROWTH 125 7.6 CHANGE MANAGEMENT 126 7.6.1 RISING ADOPTION OF CHANGE MANAGEMENT SOLUTIONS TO STRENGTHEN COMPLIANCE AND QUALITY TO BOOST MARKET 126   7.7 COMPLAINT MANAGEMENT 127 7.7.1 GROWING USE OF COMPLAINT MANAGEMENT SYSTEMS TO STRENGTHEN PATIENT SAFETY AND REGULATORY COMPLIANCE TO PROPEL MARKET 127 7.8 TRAINING MANAGEMENT 128 7.8.1 STRENGTHENING WORKFORCE READINESS WITH TRAINING MANAGEMENT TOOLS TO CONTRIBUTE TO MARKET GROWTH 128 7.9 OTHER FUNCTIONS 129 8 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE 131 8.1 INTRODUCTION 132 8.2 QUALITY REPORTING 132 8.2.1 ADVANTAGES SUCH AS STRUCTURED COLLECTION AND ANALYSIS OF PHYSICIAN PERFORMANCE TO BOOST MARKET 132 8.3 BUSINESS INTELLIGENCE & ANALYTICS 133 8.3.1 DEPLOYMENT OF ADVANCED ANALYTICS TO STRENGTHEN EFFICIENCY AND ACCOUNTABILITY TO DRIVE GROWTH 133 8.4 CLINICAL RISK MANAGEMENT 134 8.4.1 ADOPTION OF CLINICAL RISK MANAGEMENT TO ENHANCE PATIENT SAFETY, CARE QUALITY, AND ORGANIZATIONAL RESILIENCE 134 8.5 PROVIDER PERFORMANCE MANAGEMENT 135 8.5.1 OPTIMIZING CLINICIAN AND NETWORK PERFORMANCE THROUGH DATA-DRIVEN QUALITY MANAGEMENT IN HEALTHCARE TO SUPPORT GROWTH 135 8.6 REGULATORY & ACCREDITATION COMPLIANCE 136 8.6.1 ENHANCING HEALTHCARE QUALITY THROUGH PROACTIVE REGULATORY AND ACCREDITATION COMPLIANCE MANAGEMENT TO DRIVE MARKET 136 8.7 PATIENT EXPERIENCE & ENGAGEMENT 137 8.7.1 ENHANCING PATIENT EXPERIENCE AND ENGAGEMENT TO STRENGTHEN CARE QUALITY AND OPERATIONAL PERFORMANCE TO PROPEL MARKET 137 9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER 139 9.1 INTRODUCTION 140 9.2 HEALTHCARE PROVIDERS 140 9.2.1 HOSPITALS 141 9.2.1.1 Growing implementation of standardized care protocols and compliance measures to drive demand 141 9.2.2 OUTPATIENT & AMBULATORY CARE CENTERS 143 9.2.2.1 Growing need to streamline workflows and improve patient access to boost market 143 9.2.3 PHYSICIAN & GROUP PRACTICES 143 9.2.3.1 Ability to enhance care coordination and performance tracking to drive adoption 143 9.2.4 LONG-TERM CARE & POST-ACUTE FACILITIES 144 9.2.4.1 Benefits such as optimized patient safety and operational efficiency to fuel growth 144 9.2.5 OTHER HEALTHCARE PROVIDERS 145   9.3 HEALTHCARE PAYERS 146 9.3.1 PUBLIC PAYERS 147 9.3.1.1 Leveraging data-driven insights to improve population health and ensure compliance to support growth 147 9.3.2 PRIVATE PAYERS 148 9.3.2.1 Ability of tools to track outcomes, identify care gaps, and optimize interventions to boost demand 148 10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION 149 10.1 INTRODUCTION 150 10.2 NORTH AMERICA 151 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 152 10.2.2 US 156 10.2.2.1 US to dominate global market for healthcare quality management (QMS) 156 10.2.3 CANADA 160 10.2.3.1 Growing government support and digital health adoption to fuel market growth 160 10.3 EUROPE 164 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 165 10.3.2 UK 169 10.3.2.1 Growing digital health infrastructure and clinical innovation to fuel market growth 169 10.3.3 GERMANY 173 10.3.3.1 Operational and regulatory challenges in Germany’s healthcare quality management (QMS) market to limit growth 173 10.3.4 FRANCE 176 10.3.4.1 National quality strategies and hospital modernization to fuel market adoption 176 10.3.5 ITALY 180 10.3.5.1 Challenges and regional disparities in Italy’s healthcare quality management (QMS) market to hinder growth 180 10.3.6 SPAIN 184 10.3.6.1 Value-based care reforms and digital reporting to drive Spain’s healthcare quality management (QMS) market 184 10.3.7 REST OF EUROPE 188 10.4 ASIA PACIFIC 192 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 193 10.4.2 JAPAN 197 10.4.2.1 Integration of AI regulations to enhance healthcare quality management (QMS) in Japan 197 10.4.3 CHINA 201 10.4.3.1 Challenges and operational barriers in China’s healthcare quality management (QMS) market to limit growth 201   10.4.4 INDIA 205 10.4.4.1 Public health reforms and regulatory oversight to drive growth in India’s healthcare quality management (QMS) market 205 10.4.5 SOUTH KOREA 209 10.4.5.1 Digital transformation to drive healthcare quality management (QMS) market in South Korea 209 10.4.6 AUSTRALIA 213 10.4.6.1 Workforce shortages and varying levels of staff training to hinder market growth 213 10.4.7 REST OF ASIA PACIFIC 217 10.5 LATIN AMERICA 221 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 221 10.5.2 BRAZIL 225 10.5.2.1 Brazil to dominate healthcare quality management (QMS) market in Latin America 225 10.5.3 MEXICO 229 10.5.3.1 Mexico to emerge as key healthcare quality management (QMS) market in Latin America 229 10.5.4 REST OF LATIN AMERICA 233 10.6 MIDDLE EAST & AFRICA 237 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 238 10.6.2 GCC COUNTRIES 242 10.6.2.1 Saudi Arabia 247 10.6.2.1.1 Regulatory reforms and Vision 2030 investments to support market growth 247 10.6.2.2 UAE 251 10.6.2.2.1 Accreditation and patient safety initiatives to drive market growth 251 10.6.2.3 Rest of Gcc Countries 254 10.6.3 REST OF MIDDLE EAST & AFRICA 258 11 COMPETITIVE LANDSCAPE 263 11.1 OVERVIEW 263 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 263 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 263 11.3 REVENUE ANALYSIS, 2020–2024 265 11.4 MARKET SHARE ANALYSIS, 2024 266 11.5 BRAND/PRODUCT COMPARISON 269 11.6 COMPANY VALUATION & FINANCIAL METRICS 270 11.6.1 FINANCIAL METRICS 270 11.6.2 COMPANY VALUATION 270   11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 270 11.7.1 STARS 271 11.7.2 EMERGING LEADERS 271 11.7.3 PERVASIVE PLAYERS 271 11.7.4 PARTICIPANTS 271 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 273 11.7.5.1 Company footprint 273 11.7.5.2 Region footprint 274 11.7.5.3 Offering footprint 275 11.7.5.4 Function footprint 276 11.7.5.5 Use case footprint 277 11.7.5.6 End-user footprint 278 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 279 11.8.1 PROGRESSIVE COMPANIES 279 11.8.2 RESPONSIVE COMPANIES 279 11.8.3 DYNAMIC COMPANIES 279 11.8.4 STARTING BLOCKS 279 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 281 11.8.5.1 Detailed list of key startups/SMEs 281 11.8.5.2 Competitive benchmarking of startups/SMEs 282 11.9 COMPETITIVE SCENARIO 283 11.9.1 PRODUCT LAUNCHES & ENHANCEMENTS 283 11.9.2 DEALS 284 11.9.3 OTHER DEVELOPMENTS 285 12 COMPANY PROFILES 286 12.1 KEY PLAYERS 286 12.1.1 NUANCE COMMUNICATIONS, INC. (MICROSOFT) 286 12.1.1.1 Business overview 286 12.1.1.2 Products & services offered 287 12.1.1.3 Recent developments 288 12.1.1.3.1 Deals 288 12.1.1.4 MnM view 288 12.1.1.4.1 Right to win 288 12.1.1.4.2 Strategic choices 289 12.1.1.4.3 Weaknesses & competitive threats 289   12.1.2 PREMIER INC. 290 12.1.2.1 Business overview 290 12.1.2.1.1 Products & services offered 291 12.1.2.2 Recent developments 292 12.1.2.2.1 Product enhancements 292 12.1.2.2.2 Deals 292 12.1.2.3 MnM view 293 12.1.2.3.1 Right to win 293 12.1.2.3.2 Strategic choices 293 12.1.2.3.3 Weaknesses & competitive threats 293 12.1.3 OPTUM, INC. (UNITEDHEALTH GROUP) 294 12.1.3.1 Business overview 294 12.1.3.2 Products & services offered 295 12.1.3.3 Recent developments 296 12.1.3.3.1 Product launches & enhancements 296 12.1.3.3.2 Deals 296 12.1.3.4 MnM view 297 12.1.3.4.1 Right to win 297 12.1.3.4.2 Strategic choices 297 12.1.3.4.3 Weaknesses & competitive threats 297 12.1.4 INTELEX TECHNOLOGIES (FORTIVE) 298 12.1.4.1 Business overview 298 12.1.4.2 Products & services offered 299 12.1.4.3 Recent developments 300 12.1.4.3.1 Product launches & enhancements 300 12.1.4.3.2 Expansions 300 12.1.4.4 MnM view 301 12.1.4.4.1 Right to win 301 12.1.4.4.2 Strategic choices 301 12.1.4.4.3 Weaknesses & competitive threats 301 12.1.5 DNV 302 12.1.5.1 Business overview 302 12.1.5.2 Products & services offered 303 12.1.5.3 Recent developments 304 12.1.5.3.1 Product launches 304 12.1.5.3.2 Deals 304 12.1.5.4 MnM view 304 12.1.5.4.1 Right to win 304 12.1.5.4.2 Strategic choices 305 12.1.5.4.3 Weaknesses & competitive threats 305   12.1.6 RLDATIX 306 12.1.6.1 Business overview 306 12.1.6.2 Products & services offered 306 12.1.6.3 Recent developments 307 12.1.6.3.1 Product launches & enhancements 307 12.1.6.3.2 Deals 307 12.1.6.3.3 Other developments 308 12.1.6.4 MnM view 308 12.1.6.4.1 Right to win 308 12.1.6.4.2 Strategic choices 308 12.1.6.4.3 Weaknesses & competitive threats 308 12.1.7 RISKONNECT, INC. 309 12.1.7.1 Business overview 309 12.1.7.2 Products & services offered 309 12.1.7.3 Recent developments 310 12.1.7.3.1 Product enhancements 310 12.1.7.3.2 Deals 310 12.1.8 HCI 312 12.1.8.1 Business overview 312 12.1.8.2 Products & services offered 312 12.1.8.3 Recent developments 313 12.1.8.3.1 Product launches 313 12.1.8.3.2 Other developments 313 12.1.9 IDEAGEN 314 12.1.9.1 Business overview 314 12.1.9.2 Products & services offered 314 12.1.9.3 Recent developments 315 12.1.9.3.1 Product launches 315 12.1.9.3.2 Deals 315 12.1.10 MEDISOLV, INC. 316 12.1.10.1 Business overview 316 12.1.10.2 Products & services offered 316 12.1.10.3 Recent developments 317 12.1.10.3.1 Product approvals & enhancements 317 12.1.10.3.2 Deals 318 12.1.11 VĀLENZ HEALTH 319 12.1.11.1 Business overview 319 12.1.11.2 Products & services offered 319 12.1.11.3 Recent developments 320 12.1.11.3.1 Product launches 320 12.1.11.3.2 Deals 320   12.1.12 ODITEK SOLUTIONS 321 12.1.12.1 Business overview 321 12.1.12.2 Products & services offered 322 12.1.13 THE PATIENT SAFETY COMPANY (TPSC) 323 12.1.13.1 Business overview 323 12.1.13.2 Products & services offered 323 12.1.13.3 Recent developments 324 12.1.13.3.1 Product enhancements 324 12.1.14 MORCARE 325 12.1.14.1 Business overview 325 12.1.14.2 Products & services offered 325 12.1.15 YOUCOMPLY, LTD. (VICLARITY) 327 12.1.15.1 Business overview 327 12.1.15.2 Products & services offered 327 12.1.15.3 Recent developments 328 12.1.15.3.1 Product launches & enhancements 328 12.1.16 SIMPLERQMS 329 12.1.16.1 Business overview 329 12.1.16.2 Products & services offered 329 12.1.17 NAVEX GLOBAL, INC. (GOLDMAN SACHS) 330 12.1.17.1 Business overview 330 12.1.17.2 Products & services offered 331 12.1.17.3 Recent developments 332 12.1.17.3.1 Product enhancements 332 12.1.17.3.2 Deals 332 12.1.18 PROVIDERTRUST 333 12.1.18.1 Business overview 333 12.1.18.2 Products & services offered 333 12.1.18.3 Recent developments 334 12.1.18.3.1 Product launches 334 12.1.18.3.2 Deals 334 12.1.19 MEDTRAINER 335 12.1.19.1 Business overview 335 12.1.19.2 Products & services offered 335 12.1.19.3 Recent developments 336 12.1.19.3.1 Product launches 336 12.1.19.3.2 Deals 336 12.1.19.3.3 Other developments 336   12.2 OTHER PLAYERS 337 12.2.1 OKKALA SOLUTIONS PRIVATE LIMITED 337 12.2.2 SAFEQUAL 338 12.2.3 EFFIVITY TECHNOLOGIES, INC. 339 12.2.4 TITLE21 HEALTH SOLUTIONS 340 12.2.5 MEDBLAZE (INFINI) 341 12.2.6 ETASKPRO 342 12.2.7 QUALITYZE 343 12.2.8 KARMINN CONSULTANCY NETWORK 344 12.2.9 MEG 345 13 APPENDIX 346 13.1 DISCUSSION GUIDE 346 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 351 13.3 CUSTOMIZATION OPTIONS 353 13.4 RELATED REPORTS 353 13.5 AUTHOR DETAILS 354
圖表清單 List of Tables & Figures
TABLE 1 RISK ASSESSMENT: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 50 TABLE 2 HEALTHCARE QUALITY MANAGEMENT (QMS): IMPACT ANALYSIS OF MARKET DYNAMICS 60 TABLE 3 US: INTEROPERABILITY FREQUENCY AMONG NON-FEDERAL ACUTE CARE HOSPITALS, BY HOSPITAL CHARACTERISTIC (2023) 63 TABLE 4 QMS REQUIREMENTS 64 TABLE 5 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY KEY PLAYER (2024) 74 TABLE 6 INDICATIVE PRICING OF HEALTHCARE QUALITY MANAGEMENT (QMS) SOLUTIONS, BY REGION (2024) 75 TABLE 7 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: ROLE OF COMPANIES IN ECOSYSTEM 80 TABLE 8 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2025) 84 TABLE 9 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS, 2025–2026 86 TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 15 REGULATORY SCENARIO OF NORTH AMERICA 91 TABLE 16 REGULATORY SCENARIO OF EUROPE 92 TABLE 17 REGULATORY SCENARIO OF ASIA PACIFIC 92 TABLE 18 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 93 TABLE 19 REGULATORY SCENARIO OF LATIN AMERICA 93 TABLE 20 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PORTER’S FIVE FORCES ANALYSIS 94 TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 97 TABLE 22 KEY BUYING CRITERIA FOR END USERS 98 TABLE 23 UNMET NEEDS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 99 TABLE 24 END-USER EXPECTATIONS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET 100 TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES 108 TABLE 26 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 113 TABLE 27 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 28 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 29 INTEGRATED SUITES OFFERED BY MAJOR PLAYERS 115 TABLE 30 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET FOR INTEGRATED SUITES, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 31 POINT SOLUTIONS OFFERED BY MAJOR PLAYERS 116 TABLE 32 HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET FOR BY POINT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 33 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 117 TABLE 34 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 35 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR IMPLEMENTATION & TRAINING SERVICES, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 36 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR SUPPORT SERVICES, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 37 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 38 HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET FOR OTHER SERVICES, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 39 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 122 TABLE 40 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 41 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR RISK MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 42 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR AUDIT MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 43 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CAPA & NONCONFORMANCE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 44 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CHANGE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 45 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR COMPLAINT MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 46 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR TRAINING MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 47 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OTHER FUNCTIONS, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 48 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 132 TABLE 49 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PHYSICIAN QUALITY REPORTING, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 50 BUSINESS INTELLIGENCE & ANALYTICS SOLUTIONS OFFERED BY MAJOR PLAYERS 134 TABLE 51 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR BUSINESS INTELLIGENCE & ANALYTICS, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 52 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR CLINICAL RISK MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 53 PROVIDER PERFORMANCE MANAGEMENT SOLUTIONS OFFERED BY MAJOR PLAYERS 136 TABLE 54 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PROVIDER PERFORMANCE MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 55 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR REGULATORY & ACCREDITATION COMPLIANCE, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 56 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PATIENT EXPERIENCE & ENGAGEMENT, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 57 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 58 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 59 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 60 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 61 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 62 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PHYSICIAN & GROUP PRACTICES, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 63 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 64 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 65 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 66 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 67 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PUBLIC PAYERS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 68 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR PRIVATE PAYERS, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 69 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 70 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 71 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 153 TABLE 72 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 73 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 74 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 154 TABLE 75 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 155 TABLE 76 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 77 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 78 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 79 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 157 TABLE 80 US: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 81 US: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 82 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 158 TABLE 83 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 159 TABLE 84 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 85 US: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 86 US: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 87 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 161 TABLE 88 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 89 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 90 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 162 TABLE 91 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 163 TABLE 92 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 93 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 94 CANADA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 95 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 96 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 166 TABLE 97 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 98 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 99 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 167 TABLE 100 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 167 TABLE 101 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 168 TABLE 102 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 103 EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 104 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 169 TABLE 105 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 106 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 107 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 171 TABLE 108 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 171 TABLE 109 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 110 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 111 UK: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 112 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 173 TABLE 113 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 114 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 115 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 174 TABLE 116 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 175 TABLE 117 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 118 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 119 GERMANY: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 120 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 177 TABLE 121 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 122 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 123 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 178 TABLE 124 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 179 TABLE 125 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 126 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 127 FRANCE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 128 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 181 TABLE 129 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 130 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 131 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 182 TABLE 132 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 183 TABLE 133 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 134 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 135 ITALY: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 136 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 185 TABLE 137 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 138 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 139 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 186 TABLE 140 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 187 TABLE 141 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 142 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 143 SPAIN: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 144 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 189 TABLE 145 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 146 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 147 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 190 TABLE 148 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 191 TABLE 149 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 191 TABLE 150 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 151 REST OF EUROPE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 152 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 153 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 194 TABLE 154 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 155 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 156 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 195 TABLE 157 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 196 TABLE 158 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 196 TABLE 159 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 160 ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 161 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 198 TABLE 162 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 163 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 164 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 199 TABLE 165 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 200 TABLE 166 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 167 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 168 JAPAN: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 169 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 202 TABLE 170 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 171 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 172 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 203 TABLE 173 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 204 TABLE 174 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 204 TABLE 175 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 176 CHINA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 177 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 206 TABLE 178 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 179 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 180 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 207 TABLE 181 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 208 TABLE 182 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 183 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 184 INDIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 185 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 210 TABLE 186 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 187 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 188 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 211 TABLE 189 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 212 TABLE 190 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 191 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 192 SOUTH KOREA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 193 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 214 TABLE 194 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 195 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 196 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 215 TABLE 197 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 216 TABLE 198 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 216 TABLE 199 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 200 AUSTRALIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 201 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 218 TABLE 202 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 203 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 204 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 219 TABLE 205 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 219 TABLE 206 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 207 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 208 REST OF ASIA PACIFIC: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 209 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 210 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 222 TABLE 211 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 212 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 213 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 223 TABLE 214 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 224 TABLE 215 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 224 TABLE 216 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 217 LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 218 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 226 TABLE 219 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 220 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 221 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 227 TABLE 222 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 228 TABLE 223 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 228 TABLE 224 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 225 BRAZIL: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 226 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 230 TABLE 227 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 228 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 229 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 231 TABLE 230 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 232 TABLE 231 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 232 TABLE 232 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 233 MEXICO: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 234 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 234 TABLE 235 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 236 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 237 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 235 TABLE 238 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 236 TABLE 239 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 240 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 241 REST OF LATIN AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 242 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY REGION, 2023–2030 (USD MILLION) 239 TABLE 243 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 239 TABLE 244 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 245 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 246 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 240 TABLE 247 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 241 TABLE 248 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 241 TABLE 249 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 250 MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 251 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 252 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 243 TABLE 253 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 254 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 255 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 245 TABLE 256 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 245 TABLE 257 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 258 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 259 GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 260 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 247 TABLE 261 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 262 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 263 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 249 TABLE 264 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 249 TABLE 265 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 250 TABLE 266 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 267 SAUDI ARABIA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 268 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 251 TABLE 269 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 270 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 271 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 252 TABLE 272 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 253 TABLE 273 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 253 TABLE 274 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 275 UAE: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 276 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 255 TABLE 277 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 278 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 279 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 256 TABLE 280 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 257 TABLE 281 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 282 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 283 REST OF GCC COUNTRIES: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 284 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2023–2030 (USD MILLION) 259 TABLE 285 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 286 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 287 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 260 TABLE 288 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2023–2030 (USD MILLION) 261 TABLE 289 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2023–2030 (USD MILLION) 261 TABLE 290 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 291 REST OF MIDDLE EAST & AFRICA: HEALTHCARE QUALITY MANAGEMENT (QMS) FOR HEALTHCARE PAYERS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 292 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS), JANUARY 2022–SEPTEMBER 2025 263 TABLE 293 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEGREE OF COMPETITION 267 TABLE 294 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: REGION FOOTPRINT 274 TABLE 295 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: OFFERING FOOTPRINT 275 TABLE 296 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: FUNCTION FOOTPRINT 276 TABLE 297 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: USE CASE FOOTPRINT 277 TABLE 298 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: END-USER FOOTPRINT 278 TABLE 299 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 281 TABLE 300 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 282 TABLE 301 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION 282 TABLE 302 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 283 TABLE 303 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 284 TABLE 304 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 285 TABLE 305 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY OVERVIEW 286 TABLE 306 NUANCE COMMUNICATIONS, INC. (MICROSOFT): PRODUCTS & SERVICES OFFERED 287 TABLE 307 NUANCE COMMUNICATIONS, INC. (MICROSOFT): DEALS, JANUARY 2022–SEPTEMBER 2025 288 TABLE 308 PREMIER INC.: COMPANY OVERVIEW 290 TABLE 309 PREMIER INC.: PRODUCTS & SERVICES OFFERED 291 TABLE 310 PREMIER INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 292 TABLE 311 PREMIER INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 292 TABLE 312 OPTUM, INC. (UNITEDHEALTH GROUP): COMPANY OVERVIEW 294 TABLE 313 OPTUM, INC. (UNITEDHEALTH GROUP): PRODUCTS & SERVICES OFFERED 295 TABLE 314 OPTUM, INC. (UNITEDHEALTH GROUP): PRODUCT LAUNCHES & ENHANCEMENTS, ENHANCEMENT, JANUARY 2022–SEPTEMBER 2025 296 TABLE 315 OPTUM, INC. (UNITEDHEALTH GROUP): DEALS, JANUARY 2022–SEPTEMBER 2025 296 TABLE 316 INTELEX TECHNOLOGIES (FORTIVE): COMPANY OVERVIEW 298 TABLE 317 INTELEX TECHNOLOGIES (FORTIVE): PRODUCTS & SERVICES OFFERED 299 TABLE 318 INTELEX TECHNOLOGIES (FORTIVE): PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 300 TABLE 319 INTELEX TECHNOLOGIES (FORTIVE): EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 300 TABLE 320 DNV: COMPANY OVERVIEW 302 TABLE 321 DNV: PRODUCTS & SERVICES OFFERED 303 TABLE 322 DNV: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 304 TABLE 323 DNV: DEALS, JANUARY 2022–SEPTEMBER 2025 304 TABLE 324 RLDATIX: COMPANY OVERVIEW 306 TABLE 325 RLDATIX: PRODUCTS & SERVICES OFFERED 306 TABLE 326 RLDATIX: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 307 TABLE 327 RLDATIX: DEALS, JANUARY 2022–SEPTEMBER 2025 307 TABLE 328 RLDATIX: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 308 TABLE 329 RISKONNECT, INC.: COMPANY OVERVIEW 309 TABLE 330 RISKONNECT, INC.: PRODUCTS & SERVICES OFFERED 309 TABLE 331 RISKONNECT, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 310 TABLE 332 RISKONNECT, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 310 TABLE 333 HCI: COMPANY OVERVIEW 312 TABLE 334 HCI: PRODUCTS & SERVICES OFFERED 312 TABLE 335 HCI: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 313 TABLE 336 HCI: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 313 TABLE 337 IDEAGEN: COMPANY OVERVIEW 314 TABLE 338 IDEAGEN: PRODUCTS & SERVICES OFFERED 314 TABLE 339 IDEAGEN: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 315 TABLE 340 IDEAGEN: DEALS, JANUARY 2022–SEPTEMBER 2025 315 TABLE 341 MEDISOLV, INC.: COMPANY OVERVIEW 316 TABLE 342 MEDISOLV, INC.: PRODUCTS & SERVICES OFFERED 316 TABLE 343 MEDISOLV, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 317 TABLE 344 MEDISOLV, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 318 TABLE 345 VĀLENZ HEALTH: COMPANY OVERVIEW 319 TABLE 346 VĀLENZ HEALTH: PRODUCTS & SERVICES OFFERED 319 TABLE 347 VĀLENZ HEALTH: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 320 TABLE 348 VĀLENZ HEALTH: DEALS, JANUARY 2022–SEPTEMBER 2025 320 TABLE 349 ODITEK SOLUTIONS: COMPANY OVERVIEW 321 TABLE 350 ODITEK SOLUTIONS: PRODUCTS & SERVICES OFFERED 322 TABLE 351 THE PATIENT SAFETY COMPANY (TPSC): COMPANY OVERVIEW 323 TABLE 352 THE PATIENT SAFETY COMPANY (TPSC): PRODUCTS & SERVICES OFFERED 323 TABLE 353 THE PATIENT SAFETY COMPANY (TPSC): PRODUCT ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 324 TABLE 354 MORCARE: COMPANY OVERVIEW 325 TABLE 355 MORCARE: PRODUCTS & SERVICES OFFERED 325 TABLE 356 YOUCOMPLY, LTD. (VICLARITY): COMPANY OVERVIEW 327 TABLE 357 YOUCOMPLY, LTD. (VICLARITY): PRODUCTS & SERVICES OFFERED 327 TABLE 358 YOUCOMPLY, LTD. (VICLARITY): PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 328 TABLE 359 SIMPLERQMS: COMPANY OVERVIEW 329 TABLE 360 SIMPLERQMS: PRODUCTS & SERVICES OFFERED 329 TABLE 361 NAVEX GLOBAL, INC. (GOLDMAN SACHS): COMPANY OVERVIEW 330 TABLE 362 NAVEX GLOBAL, INC. (GOLDMAN SACHS): PRODUCTS & SERVICES OFFERED 331 TABLE 363 NAVEX GLOBAL, INC. (GOLDMAN SACHS): PRODUCT ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 332 TABLE 364 NAVEX GLOBAL, INC. (GOLDMAN SACHS): DEALS, JANUARY 2022–SEPTEMBER 2025 332 TABLE 365 PROVIDERTRUST: COMPANY OVERVIEW 333 TABLE 366 PROVIDERTRUST: PRODUCTS & SERVICES OFFERED 333 TABLE 367 PROVIDERTRUST: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 334 TABLE 368 PROVIDERTRUST: DEALS, JANUARY 2022–SEPTEMBER 2025 334 TABLE 369 MEDTRAINER: COMPANY OVERVIEW 335 TABLE 370 MEDTRAINER: PRODUCTS & SERVICES OFFERED 335 TABLE 371 MEDTRAINER: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 336 TABLE 372 MEDTRAINER: DEALS, JANUARY 2022–SEPTEMBER 2025 336 TABLE 373 MEDTRAINER: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2025 336 TABLE 374 OKKALA SOLUTIONS PRIVATE LIMITED: COMPANY OVERVIEW 337 TABLE 375 SAFEQUAL: COMPANY OVERVIEW 338 TABLE 376 EFFIVITY TECHNOLOGIES, INC.: COMPANY OVERVIEW 339 TABLE 377 TITLE21 HEALTH SOLUTIONS: COMPANY OVERVIEW 340 TABLE 378 MEDBLAZE (INFINI): COMPANY OVERVIEW 341 TABLE 379 ETASKPRO: COMPANY OVERVIEW 342 TABLE 380 QUALITYZE: COMPANY OVERVIEW 343 TABLE 381 KARMINN CONSULTANCY NETWORK: COMPANY OVERVIEW 344 TABLE 382 MEG: COMPANY OVERVIEW 345 FIGURE 1 HEALTHCARE QUALITY MANAGEMENT MARKET SEGMENTATION & REGIONAL SCOPE 35 FIGURE 2 RESEARCH DESIGN 40 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43 FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 45 FIGURE 5 BOTTOM-UP APPROACH 46 FIGURE 6 TOP-DOWN APPROACH 46 FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEALTHCARE QUALITY MANAGEMENT (QMS) INDUSTRY 47 FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48 FIGURE 9 DATA TRIANGULATION METHODOLOGY 49 FIGURE 10 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 51 FIGURE 11 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION) 52 FIGURE 12 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY USE CASE, 2025 VS. 2030 (USD MILLION) 53 FIGURE 13 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 53 FIGURE 14 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: GEOGRAPHIC SNAPSHOT 54 FIGURE 15 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT INITIATIVES TO DRIVE MARKET 56 FIGURE 16 SOFTWARE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 57 FIGURE 17 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 57 FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 58 FIGURE 19 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 58 FIGURE 20 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59 FIGURE 21 US: ENGAGEMENT WITH AND FREQUENCY OF INTEROPERABLE EXCHANGE AMONG NON-FEDERAL ACUTE CARE HOSPITALS, 2018–2023 63 FIGURE 22 PATIENT-GENERATED HEALTH DATA USE CASE 66 FIGURE 23 HEALTHCARE DATA BREACHES (2009–2025) 68 FIGURE 24 INDIVIDUALS AFFECTED BY HEALTHCARE DATA BREACHES (2009–2025) 68 FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71 FIGURE 26 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: VALUE CHAIN ANALYSIS 77 FIGURE 27 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: ECOSYSTEM ANALYSIS 79 FIGURE 28 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: INVESTMENT & FUNDING SCENARIO 81 FIGURE 29 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2025) 84 FIGURE 30 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: TOP PATENT OWNERS/PATENTING TRENDS, 2015–2025 85 FIGURE 31 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: PORTER’S FIVE FORCES ANALYSIS 95 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 97 FIGURE 33 KEY BUYING CRITERIA FOR END USERS 98 FIGURE 34 MARKET POTENTIAL OF AI/GEN AI ON HEALTHCARE QUALITY MANAGEMENT (QMS) ACROSS INDUSTRIES 103 FIGURE 35 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105 FIGURE 36 NUMBER OF US HOSPITALS, BY TYPE (2025) 142 FIGURE 37 US HEALTH INSURANCE INDUSTRY (DIRECT HALTH PREMIUM), 2024 146 FIGURE 38 NORTH AMERICA: HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET SNAPSHOT 152 FIGURE 39 ASIA PACIFIC: HEALTHCRE QUALITY MANAGEMENT (QMS) MARKET SNAPSHOT 193 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET, 2020–2024 266 FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET (2024) 267 FIGURE 42 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 269 FIGURE 43 EV/EBITDA OF KEY VENDORS 270 FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 270 FIGURE 45 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY EVALUATION QUADRANT (KEY PLAYERS), 2024 272 FIGURE 46 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY FOOTPRINT 273 FIGURE 47 HEALTHCARE QUALITY MANAGEMENT (QMS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 280 FIGURE 48 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY SNAPSHOT (2025) 287 FIGURE 49 PREMIER INC.: COMPANY SNAPSHOT (2025) 291 FIGURE 50 OPTUM, INC. (UNITEDHEALTH GROUP): COMPANY SNAPSHOT (2024) 295 FIGURE 51 INTELEX TECHNOLOGIES (FORTIVE): COMPANY SNAPSHOT (2024) 299 FIGURE 52 DNV: COMPANY SNAPSHOT (2024) 303 FIGURE 53 NAVEX GLOBAL, INC. (GOLDMAN SACHS): COMPANY SNAPSHOT (2024) 331

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們